<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059795</url>
  </required_header>
  <id_info>
    <org_study_id>Im/2019/2917</org_study_id>
    <nct_id>NCT05059795</nct_id>
  </id_info>
  <brief_title>Volume Resuscitation in Cirrhosis With Sepsis Induced Hypotension</brief_title>
  <official_title>To Compare the Effectiveness of Various Methods of Estimating Volume Resuscitation in Patients With Cirrhosis With Sepsis Induced Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In critically ill patients with liver disease, fluid therapy needs to be instituted after&#xD;
      identification of patients who will be fluid responsive and initiate appropriate inotropes&#xD;
      early to prevent the mortality associated with fluid overload.&#xD;
&#xD;
      The parameters and methodology used for assessing fluid responsiveness have been studied&#xD;
      earlier, but the optimum method is not established. Existing recommendations based on data&#xD;
      regarding fluid responsiveness and choice of fluid for resuscitation from intensive care&#xD;
      units in general cannot be applied to those with liver disease as the hemodynamic alterations&#xD;
      that occur with liver disease, presence of hypoalbuminemia at baseline and presence of&#xD;
      cardiac dysfunction interfere with the conventional methods of fluid status assessment, fluid&#xD;
      responsiveness as well as the response to different types of resuscitation fluids.&#xD;
&#xD;
      Therefore the investigators attempt to compare various methods to estimate current&#xD;
      intravascular volume status of patient which could be helpful in guiding fluid therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:&#xD;
&#xD;
        1. To compare the accuracy of central venous pressure and inferior vena cava dynamic&#xD;
           assessment and lactate clearance for estimating adequacy of fluid resuscitation in&#xD;
           patients with cirrhosis with sepsis induced hypotension .[Time Frame at enrolment, 6&#xD;
           hours, 24 hours]&#xD;
&#xD;
        2. Predictors of all-cause mortality at Day 7 and day 28. [Time Frame Day 7 and Day 28]&#xD;
&#xD;
      PATIENTS AND METHODS Study Design: A Prospective observational study&#xD;
&#xD;
      Case Definition:&#xD;
&#xD;
      Cirrhosis will be defined by - &quot;clinical features consistent with chronic liver disease (CLD)&#xD;
      including a consistent history as well as a documented complication of CLD (i.e., ascites,&#xD;
      varices, hepatic encephalopathy) and/or imaging results consistent with cirrhosis and/or&#xD;
      liver histologic findings consistent with cirrhosis&quot;&#xD;
&#xD;
      Systemic Inflammatory Response Syndrome (SIRS) - 2 more of following 4&#xD;
&#xD;
        1. Oral temperature &gt;38.3oC or &lt;36oC&#xD;
&#xD;
        2. Heart Rate &gt; 90 beats/min&#xD;
&#xD;
        3. Respiratory Rate &gt;20 breaths/min or PaCO2 &lt;32mmHg&#xD;
&#xD;
        4. WBC count &gt;12000/cumm, &lt;4000/cumm or &gt;10% immature band forms Sepsis is a SIRS in&#xD;
           response to proven or suspected microbial event 'Sepsis induced hypotension' implies&#xD;
           mean arterial pressure &lt; 65 mmHg or a reduction of &gt;40 mm Hg from baseline in the&#xD;
           absence of other causes of hypotension Severe sepsis - sepsis-induced tissue&#xD;
           hypoperfusion or organ dysfunction (any of the following thought to be due to the&#xD;
           infection)&#xD;
&#xD;
             -  Sepsis-induced hypotension&#xD;
&#xD;
             -  Lactate above upper limits laboratory normal&#xD;
&#xD;
             -  Urine output &lt; 0.5 mL/kg/hr for more than 2 hrs despite adequate fluid&#xD;
                resuscitation&#xD;
&#xD;
             -  Acute lung injury with PaO2/FIO2 &lt; 250 in the absence of pneumonia as infection&#xD;
                source&#xD;
&#xD;
             -  Acute lung injury with PaO2/FIO2 &lt; 200 in the presence of pneumonia as infection&#xD;
                source&#xD;
&#xD;
             -  Creatinine &gt; 2.0 mg/dL (176.8 μmol/L)&#xD;
&#xD;
             -  Bilirubin &gt; 2 mg/dL (34.2 μmol/L)&#xD;
&#xD;
             -  Platelet count &lt; 100,000 μL&#xD;
&#xD;
             -  Coagulopathy (international normalized ratio &gt; 1.5) Septic shock is &quot;sepsis induced&#xD;
                hypotension despite adequate fluid resuscitation along with organ dysfunction or&#xD;
                perfusion abnormality&quot;.&#xD;
&#xD;
      Acute kidney injury (AKI) is defined as any of the following:&#xD;
&#xD;
        1. Increase in SCr by ≥0.3 mg/dl (≥26.5 μmol/l) within 48 hours; or&#xD;
&#xD;
        2. Increase in SCr to ≥1.5 times baseline, which is known or presumed to have occurred&#xD;
           within the prior 7 days; or&#xD;
&#xD;
        3. Urine volume &lt;0.5 ml/kg/h for 6 hours&#xD;
&#xD;
      Definition of Adequate Intravascular volume - IVC diameter ≥ 18mm and IVCCI &lt;40% Definition&#xD;
      of Adequate fluid resuscitation - Achieving MAP ≥ 65mmHg with Fluid bolus&#xD;
&#xD;
      All patients eligible for the study will undergo screening as per the above criteria. The&#xD;
      ones who satisfy the criteria will be counselled for participation in the study and written&#xD;
      informed consent will be taken from the patient / the legal guardian in patients who are&#xD;
      unable to do so. Patient information sheets will also be signed, briefing the patients about&#xD;
      why the research work is necessary and also about the methodology.&#xD;
&#xD;
      Detail history and clinical examination will be done in all cases and the findings along with&#xD;
      all investigation results will be recorded in a standard case record form. Information would&#xD;
      be collected regarding the onset and duration of symptoms, etiology, and severity of disease,&#xD;
      other baseline clinical features, demographic characteristics, routine biochemical and&#xD;
      hematological investigations.&#xD;
&#xD;
        -  After enrolment, baseline samples would be taken for routine investigations and samples&#xD;
           for evaluation of sepsis - blood culture, urine culture, fluid cultures, procalcitonin&#xD;
           will be taken.&#xD;
&#xD;
        -  The patient would be assessed for 5 parameters and will be reassessed 30min and 4hours&#xD;
           after starting fluid resuscitation.&#xD;
&#xD;
             1. IVC diameter and collapsibility Index&#xD;
&#xD;
             2. Serum lactate levels&#xD;
&#xD;
             3. Venous-arterial pCO2 difference&#xD;
&#xD;
             4. CVP where central line inserted as per treating physician's decision&#xD;
&#xD;
             5. ScVO2 where central line available&#xD;
&#xD;
        -  The patients in septic shock where IVC diameter &lt;18mm or IVCCI≥40% in spontaneously&#xD;
           breathing patients, would be regarded in fluid depleted state and will be given&#xD;
           aggressive fluid resuscitation with 20% albumin 100 ml started within 30 min which is a&#xD;
           standard fluid of choice in patients with cirrhosis and other fluids - Normal Saline/&#xD;
           balanced salt solution 30ml/kg over 3hrs.&#xD;
&#xD;
      (The patients who not fulfil above criteria would be assumed in a fluid replete state and be&#xD;
      started on maintenance fluid management along with inotrope support as per standard dosage&#xD;
      guidelines) Norepinephrine would be 1st choice vasopressor - started at a dose of 4μg/min and&#xD;
      titrated every 20 min to a maximum of 21.3μg/min. If MAP still &lt;65mmHg, Vasopressor would be&#xD;
      added starting from a 0.01U/min to 0.04U/min. Adrenaline would be added in shock refractory&#xD;
      to both vasopressors in dose of 4-24μg/min.&#xD;
&#xD;
        -  Along with fluid and inotrope support, the patient will also receive standard of care&#xD;
           including empiric broad spectrum antibiotics, oxygen support/ventilator support if&#xD;
           needed.&#xD;
&#xD;
        -  MAP would be rechecked 30 min after starting fluid therapy. IVC diameter and IVCCI would&#xD;
           also be checked at same time to see if change in MAP (if any) is reflected in the IVC&#xD;
           status. Adequate fluid resuscitation would be defined by achieving a MAP ≥ 65mmHg. In&#xD;
           patients achieving MAP≥65mmHg, fluid therapy will be continued. The patients still&#xD;
           having MAP&lt;65 mmHg will be started on inotrope support according to standard guidelines.&#xD;
&#xD;
        -  IVC, IVCCI, Lactate, venous-arterial pCO2 difference, CVP and ScVO2 would be remeasured&#xD;
           at 4 hrs.&#xD;
&#xD;
        -  The patient would be the followed with serial examinations, calculations of SOFA score,&#xD;
           CTP and MELD.&#xD;
&#xD;
        -  Samples to test for sepsis such as procalcitonin, galactomannan, beta D Glucan and high&#xD;
           sensitivity CRP will be done every 48-72 hours as determined by the treating clinician.&#xD;
&#xD;
        -  Cultures for bacterial and fungal sepsis will be taken as per the Liver ICU protocol.&#xD;
&#xD;
        -  If discharged earlier, for the purpose of 28-day mortality the patients' kin would be&#xD;
           contacted telephonically.&#xD;
&#xD;
        -  Data regarding total amount of fluids, type of fluids, urine output, dose and duration&#xD;
           of inotropes, initiation of RRT, total days in ICU/Hospital, immediate cause of death&#xD;
           (In case of mortality) would be noted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Achievement of IVC diameter ≥ 18mm and IVCCI &lt;40%</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Achievement of Mean Arterial pressure &gt;65 mmHg</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Requirement of inotrope support (median dose)</measure>
    <time_frame>4 hours and 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Acute Kidney Injury</measure>
    <time_frame>day 0 and day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of new organ dysfunction (encephalopathy, coagulation failure, respiratory failure)</measure>
    <time_frame>Day 0 and Day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>Total duration of ICU stay in days</time_frame>
    <description>The total duration of stay in intensive care, which will be assessed till 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Total duration of admission as a hospital inpatient, assessed till 28 days</time_frame>
    <description>The total duration of stay in hospital, which will be assessed till 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Day 7 and Day 28</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Cirrhosis, Liver</condition>
  <condition>Sepsis</condition>
  <condition>Acute on Chronic Liver Failure</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and Urine Samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18-65 years age with cirrhosis of any etiology now presenting with sepsis induced&#xD;
        hypotension&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Clinical/Imaging or Biopsy proven liver cirrhosis of any etiology&#xD;
&#xD;
          2. Hypotension (MAP &lt;65mmHg or SBP &lt;90mmHg)&#xD;
&#xD;
          3. 18-65 yrs of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Already received colloid or 2 litres of fluid within the first 12 hours of&#xD;
             presentation&#xD;
&#xD;
          2. Already on vasopressors/inotropes&#xD;
&#xD;
          3. Severe pre-existing cardiopulmonary disease&#xD;
&#xD;
          4. Acute Respiratory Distress Syndrome (ARDS)&#xD;
&#xD;
          5. Active bleeding like variceal bleed 28&#xD;
&#xD;
          6. Cerebrovascular events&#xD;
&#xD;
          7. Chronic renal disease - End Stage Renal Disease (ESRD)/ patient on renal replacement&#xD;
             therapy&#xD;
&#xD;
          8. Admission to ICU following liver transplantation, burns, cardiac surgery&#xD;
&#xD;
          9. Brain death or likely brain death within 24 hours&#xD;
&#xD;
         10. Previous adverse reaction to human albumin solution&#xD;
&#xD;
         11. Pregnant or lactating women&#xD;
&#xD;
         12. Informed consent refused by patient or attendants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madhumita Premkumar, MD, DM</last_name>
      <phone>1722756344</phone>
      <phone_ext>+91</phone_ext>
      <email>drmadhumitap1@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Postgraduate Institute of Medical Education and Research</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madhumita PREMKUMAR, DM</last_name>
      <phone>01722756344</phone>
      <email>drmadhumitap@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer MF, Vanjak D, Vauquelin P, Assous M, Sicot C. Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med. 1992 Jun;20(6):746-50.</citation>
    <PMID>1597026</PMID>
  </reference>
  <reference>
    <citation>ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.</citation>
    <PMID>25272316</PMID>
  </reference>
  <reference>
    <citation>Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008 Jul;134(1):172-8. doi: 10.1378/chest.07-2331. Review.</citation>
    <PMID>18628220</PMID>
  </reference>
  <reference>
    <citation>Bentzer P, Griesdale DE, Boyd J, MacLean K, Sirounis D, Ayas NT. Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? JAMA. 2016 Sep 27;316(12):1298-309. doi: 10.1001/jama.2016.12310. Review.</citation>
    <PMID>27673307</PMID>
  </reference>
  <reference>
    <citation>Velissaris D, Pierrakos C, Scolletta S, De Backer D, Vincent JL. High mixed venous oxygen saturation levels do not exclude fluid responsiveness in critically ill septic patients. Crit Care. 2011 Jul 26;15(4):R177. doi: 10.1186/cc10326.</citation>
    <PMID>21791090</PMID>
  </reference>
  <reference>
    <citation>Lee YK, Hwang SY, Shin TG, Jo IJ, Suh GY, Jeon K. Prognostic Value of Lactate and Central Venous Oxygen Saturation after Early Resuscitation in Sepsis Patients. PLoS One. 2016 Apr 7;11(4):e0153305. doi: 10.1371/journal.pone.0153305. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0157225.</citation>
    <PMID>27054713</PMID>
  </reference>
  <reference>
    <citation>Lee J, de Louw E, Niemi M, Nelson R, Mark RG, Celi LA, Mukamal KJ, Danziger J. Association between fluid balance and survival in critically ill patients. J Intern Med. 2015 Apr;277(4):468-77. doi: 10.1111/joim.12274. Epub 2014 Jun 27.</citation>
    <PMID>24931482</PMID>
  </reference>
  <reference>
    <citation>Sefidbakht S, Assadsangabi R, Abbasi HR, Nabavizadeh A. Sonographic measurement of the inferior vena cava as a predictor of shock in trauma patients. Emerg Radiol. 2007 Jul;14(3):181-5. Epub 2007 Jun 1.</citation>
    <PMID>17541661</PMID>
  </reference>
  <reference>
    <citation>Premkumar M, Rangegowda D, Kajal K, Khumuckham JS. Noninvasive estimation of intravascular volume status in cirrhosis by dynamic size and collapsibility indices of the inferior vena cava using bedside echocardiography. JGH Open. 2019 Mar 12;3(4):322-328. doi: 10.1002/jgh3.12166. eCollection 2019 Aug.</citation>
    <PMID>31406926</PMID>
  </reference>
  <reference>
    <citation>Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, Willemsen SP, Bakker J; LACTATE study group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010 Sep 15;182(6):752-61. doi: 10.1164/rccm.200912-1918OC. Epub 2010 May 12.</citation>
    <PMID>20463176</PMID>
  </reference>
  <reference>
    <citation>Du W, Liu DW, Wang XT, Long Y, Chai WZ, Zhou X, Rui X. Combining central venous-to-arterial partial pressure of carbon dioxide difference and central venous oxygen saturation to guide resuscitation in septic shock. J Crit Care. 2013 Dec;28(6):1110.e1-5. doi: 10.1016/j.jcrc.2013.07.049.</citation>
    <PMID>24216336</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Madhumita Premkumar</investigator_full_name>
    <investigator_title>Assitant Professor</investigator_title>
  </responsible_party>
  <keyword>Resuscitation in cirrhosis</keyword>
  <keyword>Inferior vena cava dynamics</keyword>
  <keyword>Central Venous Pressure in cirrhosis</keyword>
  <keyword>Lactate clearance in cirrhosis</keyword>
  <keyword>Acute-on-chronic liver failure</keyword>
  <keyword>Sepsis in Cirrhosis</keyword>
  <keyword>Shock in ACLF and Cirrhosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Hepatic Insufficiency</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
    <mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

